We also focused on exploring the impact of resveratrol treatment on mitochondrial biogenesis in GC patients with PCOS, particularly through activating the SIRT1-PGC-1α signaling pathway. This evidence concerns the gene PPARGC1A and polycystic ovary syndrome.